ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
507.00
-80.00 (-13.63%)
At close: Jun 19, 2026
KOSDAQ:034940 Revenue
ChoA Pharmaceutical Co., LTD. had revenue of 14.68B KRW in the quarter ending March 31, 2026, with 2.15% growth. This brings the company's revenue in the last twelve months to 59.62B, down -3.73% year-over-year. In the year 2025, ChoA Pharmaceutical Co., LTD. had annual revenue of 59.31B, down -5.40%.
Revenue (ttm)
59.62B
Revenue Growth
-3.73%
P/S Ratio
0.26
Revenue / Employee
221.63M
Employees
269
Market Cap
15.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.31B | -3.38B | -5.40% |
| Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
| Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
| Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
| Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hurum | 96.85B |
| WooGene B&G | 54.75B |
| CXI Healthcare Technology Group | 51.45B |
| Seoul Pharma | 51.33B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 29.66B |
| Daesung Microbiological Labs. | 25.87B |
| BIFIDO | 17.23B |